final programconference platform

SAGO 2025 Official Aftermovie

 

Fitness Breaks at SAGO 2025

 

Dear friends,

Thank you for participating in SAGO 2025 in Prague.

I am thrilled with the feedback from participants and speakers alike. I believe that the concept of an intensive two-day conference proved successful, that the entire two days were interesting, and that the atmosphere was very open and friendly. Not to mention the world premiere of fitness breaks during the program.

All recorded lectures from the conference will also be available, after some processing, to participants on the same platform for six months after the meeting.

We will do our best to meet again in Prague at SAGO 2027.

Wishing you all the best.

David Cibula

 

Program

click here

 

Diagnostics and staging

  • Rational use of imaging methods in gynecological oncology
  • Preoperative staging of pelvic masses
  • Assessment of lymph nodes by US, PET and MRI
  • Pelvic side wall anatomy and assessment
  • Imaging guided procedures
 

Perioperative and palliative care

  • Implementation of ERAS and prehabilitation into the routine practice
  • Early palliative care and best supportive care in gynecological oncology
  • Communicating serious news effectively: Tips and tricks for a person-centered approach
 
 

Live ultrasound scanning

LIVE demonstration of ultrasound examination of patients with gynecological tumors.

 

Videosession

Demonstration of main radical surgical procedures step by step.

 
 

Systemic treatment

 

Systemic treatment of ovarian cancer

  • What is BRCA, HRD, HRR, and how they are tested
  • Biomarkers in ovarian cancer – which and when
  • Current SoA chemotherapy
  • Maintenance treatment in 1L and beyond
 

Platinum resistant recurrent ovarian cancer (PROC)

  • Current SoA treatment of PROC
  • What is ADC and how it works
  • Predictive biomarkers and their testing
  • First ADC approved in ovarian cancer in Europe
  • Challenging management of new types of toxicity
 
 

Systemic treatment

 

Management of locally advanced and metastatic cervical cancer

  • Chaos in classification (intermediate/ high risk, IB3, locally advanced disease)
  • What is the current standard treatment in locally advanced cervical cancer (chemoradiotherapy vs induction chemo vs immunotherapy)
  • First line treatment of metastatic disease
  • Tips how to manage toxicity and enhance treatment compliance

Endometrial cancer

  • Molecular classification in endometrial cancer for beginners
  • Indications of adjuvant treatment in the molecular era
  • Systemic treatment of metastatic and recurrent endometrial cancer
 

Immunotherapy and endocrine treatment

  • A guide to cancer immunotherapy
  • Principles of cancer immunotherapy strategies
  • Endocrine treatment in gynaecological tumors
  • The role of NGS and molecular tumor boards in current management
 
 

Surgical treatment

 

Early stages

  • Surgical treatment of non-epithelial and other rare ovarian tumors
  • Surgical treatment of early-stage cervical cancer in the “after SHAPE” era
  • Sentinel lymph nodes in gynecological cancers
  • Management of patients with micrometastases and isolated tumor cells in SLN
 

Fertility sparing treatment

  • Fertility preservation in cervical cancer
  • Fertility preservation in endometrial cancer
  • Management of gynecological tumors in pregnancy
 

Advanced stages

  • Secondary cytoreduction in ovarian and endometrial cancer
  • Pelvic exenterations, LEER and out-of-box procedures
 

 

Faculty

click here

 

 

Compliance

We are pleased to inform you that the State-of-the-Art Congress in Gynecologic Oncology
has been determined as compliant with MedTech Europe Code of Ethical Business Practice and EFPIA Code of Practice.

This decision is posted here.
 

 

 

SAGO 2025 SECRETARIAT
GUARANT International spol. s r.o.
Českomoravská 19, 190 00  Prague 9, Czech Republic
Phone: +420 284 001 444
E-mail: sago-secretariat@guarant.cz | Website: www.guarant.cz